These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30128035)

  • 1. Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer.
    Li J; He Y; Tan Z; Lu J; Li L; Song X; Shi F; Xie L; You S; Luo X; Li N; Li Y; Liu X; Tang M; Weng X; Yi W; Fan J; Zhou J; Qiang G; Qiu S; Wu W; Bode AM; Cao Y
    Theranostics; 2018; 8(15):4050-4061. PubMed ID: 30128035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect.
    Xiang S; Gu H; Jin L; Thorne RF; Zhang XD; Wu M
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1465-E1474. PubMed ID: 29378948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy.
    Zeng P; Lu W; Tian J; Qiao S; Li J; Glorieux C; Wen S; Zhang H; Li Y; Huang P
    J Hematol Oncol; 2022 Mar; 15(1):30. PubMed ID: 35313945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type IDH2 is a therapeutic target for triple-negative breast cancer.
    Li JJ; Yu T; Zeng P; Tian J; Liu P; Qiao S; Wen S; Hu Y; Liu Q; Lu W; Zhang H; Huang P
    Nat Commun; 2024 Apr; 15(1):3445. PubMed ID: 38658533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF‑α inhibits xenograft tumor formation by A549 lung cancer cells in nude mice via the HIF‑1α/VASP signaling pathway.
    Liu W; Chen X; He Y; Tian Y; Xu L; Ma Y; Hu P; Su K; Luo Z; Wei L; Zhang J
    Oncol Rep; 2019 Apr; 41(4):2418-2430. PubMed ID: 30816548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
    Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
    Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF‑κB/HIF‑1α pathway in lung cancer.
    Li J; Zhang J; Xie F; Peng J; Wu X
    Int J Mol Med; 2018 Feb; 41(2):1062-1068. PubMed ID: 29207023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells.
    Li Y; Zhao L; Qi Y; Yang X
    Mol Med Rep; 2019 Jun; 19(6):4935-4945. PubMed ID: 31059086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells.
    Tanaka H; Sasayama T; Tanaka K; Nakamizo S; Nishihara M; Mizukawa K; Kohta M; Koyama J; Miyake S; Taniguchi M; Hosoda K; Kohmura E
    J Neurooncol; 2013 Feb; 111(3):273-83. PubMed ID: 23263745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium chloride decreases proliferation and migration of C6 glioma cells harboring isocitrate dehydrogenase 2 mutant via GSK-3β.
    Fu Y; Zheng Y; Chan KG; Liang A; Hu F
    Mol Biol Rep; 2014 Jun; 41(6):3907-13. PubMed ID: 24549719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT3-Mediated Dimerization of IDH2 Directs Cancer Cell Metabolism and Tumor Growth.
    Zou X; Zhu Y; Park SH; Liu G; O'Brien J; Jiang H; Gius D
    Cancer Res; 2017 Aug; 77(15):3990-3999. PubMed ID: 28536275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants.
    Gao M; Zhu H; Fu L; Li Y; Bao X; Fu H; Quan H; Wang L; Lou L
    Cancer Sci; 2019 Oct; 110(10):3306-3314. PubMed ID: 31361380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new functional IDH2 genetic variant is associated with the risk of lung cancer.
    Li J; Lu J; He Y; Wu Y; Wu Y; Song X; Jiang Y; Tang M; Weng X; Yi W; Luo X; Sun L; Bode AM; Cao Y
    Mol Carcinog; 2017 Mar; 56(3):1082-1087. PubMed ID: 27649069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of isocitrate dehydrogenase 1 induces glioma cell proliferation via nuclear factor-κB activation in a hypoxia-inducible factor 1-α dependent manner.
    Wang G; Sai K; Gong F; Yang Q; Chen F; Lin J
    Mol Med Rep; 2014 May; 9(5):1799-805. PubMed ID: 24626950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization.
    Ward PS; Lu C; Cross JR; Abdel-Wahab O; Levine RL; Schwartz GK; Thompson CB
    J Biol Chem; 2013 Feb; 288(6):3804-15. PubMed ID: 23264629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2.
    Lin AP; Abbas S; Kim SW; Ortega M; Bouamar H; Escobedo Y; Varadarajan P; Qin Y; Sudderth J; Schulz E; Deutsch A; Mohan S; Ulz P; Neumeister P; Rakheja D; Gao X; Hinck A; Weintraub ST; DeBerardinis RJ; Sill H; Dahia PL; Aguiar RC
    Nat Commun; 2015 Jul; 6():7768. PubMed ID: 26178471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway.
    Yan X; Yang C; Hu W; Chen T; Wang Q; Pan F; Qiu B; Tang B
    Oncol Rep; 2020 Jul; 44(1):103-114. PubMed ID: 32627037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of the gene encoding the IDH1 subunit of NAD(+)-dependent isocitrate dehydrogenase from Saccharomyces cerevisiae.
    Cupp JR; McAlister-Henn L
    J Biol Chem; 1992 Aug; 267(23):16417-23. PubMed ID: 1644826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism.
    Li H; Li JJ; Lu W; Yang J; Xia Y; Huang P
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic analysis of NAD(+)-isocitrate dehydrogenase with altered isocitrate binding sites: contribution of IDH1 and IDH2 subunits to regulation and catalysis.
    Cupp JR; McAlister-Henn L
    Biochemistry; 1993 Sep; 32(36):9323-8. PubMed ID: 8369302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.